Phosphorylated mammalian target of rapamycin is associated with an adverse outcome in oral squamous cell carcinoma

The effect of p-mTOR in OS of OSCC suggests that this marker may serve as a reliable biological marker to identify high-risk subgroups and as a guide to therapy. Furthermore, the high expression of p-mTOR suggests that this protein may be a promising therapeutic target in OSCC.